Analysis of interleukin-4 receptor α chain variants in multiple sclerosis

Journal of Neuroimmunology

Volumn 113, Issue 2, 2001, Pages 240-248

  Hackstein, H ^a   Bitsch, A ^a   Bohnert, A ^a   Hofmann, H ^a   Weber, F ^a   Ohly, A ^a   Linington, C ^a   Maurer M ^a   Poser, S ^a   Rieckmann, P ^a   Bein, G ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Human IL 4 receptor; MOG autoantibodies; Multiple sclerosis

Indexed keywords

HLA DR ANTIGEN; INTERLEUKIN 4 RECEPTOR; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; RECEPTOR ANTIBODY; RECEPTOR SUBUNIT;

ALLELE; ALPHA CHAIN; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE PREDISPOSITION; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR GENE; RISK FACTOR;

ADULT; AUTOANTIBODIES; FEMALE; GENE FREQUENCY; GENOTYPE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELIN-ASSOCIATED GLYCOPROTEIN; POLYMERASE CHAIN REACTION; PROTEIN ISOFORMS; RECEPTORS, INTERLEUKIN-4; REFERENCE VALUES; VARIATION (GENETICS);

EID: 0035866045     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00455-0     Document Type: Article

References (53)

1. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat
2. The role of B cells and autoantibodies in multiple sclerosis
3. Recommendations for a nomenclature system for human gene mutations
4. Rapid HLA-DRB1 genotyping by nested PCR amplification
5. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG)
6. The genetics of multiple sclerosis: Principles, background and updated results of the United Kingdom systematic genome screen
7. HLA typing in the United Kingdom multiple sclerosis genome screen
8. Common polymorphisms in the coding part of the IL4-receptor gene
9. A full genome search in multiple sclerosis
10. Genetic predisposition to multiple sclerosis as revealed by immunoprinting
11. Identification of autoantibodies associated with myelin damage in multiple sclerosis
12. Definition of human interleukin-4 receptor α chain haplotypes and allelic association with atopy markers
13. The IL-4 receptor alpha-chain variant Q576R is strongly associated with decreased kidney allograft survival
14. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex
15. Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis
16. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor
17. The role of autoimmune T lymphocytes in the pathogenesis of multiple sclerosis
18. Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily
19. Signal transduction via the interleukin-4 receptor and its correlation with atopy
20. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions
21. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction
22. Genomewide scan of multiple sclerosis in Finnish multiplex families
23. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
24. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease
25. Defining the clinical course of multiple sclerosis: Results of an international survey
26. Distinct patterns of MS pathology indicates heterogeneity in pathogenesis
27. Application of the Poser criteria in primary progressive multiple sclerosis
28. An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis
29. Crossregulation between Th1 and Th2 cells
30. The British Isles survey of multiple sclerosis in twins
31. Lack of association of atopy/asthma and the interleukin-4 receptor alpha gene in Japanese
32. Primarily chronic progressive and relapsing/remitting multiple sclerosis: Two immunogenetically distinct disease entities
33. HLA class II-associated genetic susceptibility in multiple sclerosis: A critical evaluation
34. Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis
35. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement
36. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
37. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease
38. Demyelination in primate autoimmune encephalomyelitis and acute MS lesions: A case for antigen-specific antibody mediation
39. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis
40. Clinical concordance in sibling pairs with multiple sclerosis
41. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting MS is associated with disease activity
42. Multiple sclerosis: Updated risks for relatives
43. A population-based study of multiple sclerosis in twins: Update
44. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22
45. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis
46. Pathology and pathogenesis of demyelinating diseases
47. Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination
48. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology
49. Primary progressive multiple sclerosis
50. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2(15)+multiple sclerosis
51. Major histocompatibility complex class II alleles and the course and outcome of MS: A population-based study
52. Remembering MOG: Autoantibody mediated demyelination in multiple sclerosis?
53. Index rating for diagnostic test